This person is not registered. Is this you?

Profile Details
Y Zhang

University of Arizona

Institute for Physiological Chemistry
Institute of Life Science

AntiCancer, inc

Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, HKSAR, China

College of Pharmacy, Wuhan University, China

Fudan University
Department of Pulmonary Medicine

Limerick NeuroSciences, Inc

Liquidia Technologies, Inc. UNC School of Pharmacy

Peking Union Medical College, Tsinghua University
Institute for Interdisciplinary Information Sciences

Second Military Medical University
Department of Medical Genetics

Sichuan University, Chengdu, China

Sun Yat-Sen Univ. of Medical Sciences

Vanderbilt University
Department of Biochemistry

Yahatanishi-ku University , Kitakyushu

Yong Loo Lin School of Medicine National University of Singapore

National Sun Yat-Sen University

Zhengzhou University

Cardiff University

Histology & Pharmacology, Nanjing Medical University

Center for Human Genome Research, Huazhong University of Science and Technology
Department of Hematology

Peking University Research Center on Aging, Peking University Health Science Center,

Texas Tech University Health Sciences Center

Cancer Center, Qilu Hospital of Shandong University

First Affiliated Hospital of Jinan University

China Medical University
Department of Ultrasound

Daping Hospital, The Third Military Medical University
Department of Biochemistry and Molecular Biology

Jinling Hospital, Nanjing University School of Medicine,

School of Public Health, Anhui Medical University

University of Virginia Health System
Department of Microbiology

McMaster University, Hamilton General Hospital
Department of Clinical Epidemiology

Southeast University

China Pharmaceutical University

The Hong Kong Polytechnic University

Tongji Hospital of Tongji University
Department of Hematology

Zhejiang University
Department of Clinical Laboratory

Arizona State UniversitY

The University of North Carolina at Chapel Hill
Department of Radiation Oncology and Lineberger Comprehensive Cancer Center

The University of Hong Kong

Gent University
Department of Physiological Genomics

Nankai University
Department of Biochemistry

East China Normal University

Xi'an Jiaotong University
Department of Thoracic Surgery and Oncology

University of Minnesota School of Medicine

Columbia University Medical Center
b Department of Pathology

The University of Texas MD Anderson Cancer Center
Department of Experimental Radiation Oncology

Johns Hopkins Medicine
Institute of Biliary Tract Disease

Shanghai Jiao Tong University School of Pharmacy
Department of General Surgery

The Fourth Military Medical University

University of Texas at El Paso USA

Harbin Medical University

Sun Yat-sen University Cancer Center,
Department of Radiation Oncology

Medical College of Soochow University
Department of General Surgery

Fudan University Shanghai Cancer Center
Department of Thoracic Surgery

Dalian Medical University
Department of Gastrointestinal Surgery

Nantong University
Department of Burns and Plastic Surgery

Xuzhou Medical University

Xiang Ya Nursing School of Central South University
Department of Pathology

University of Chinese Academy of Sciences

Physikdepartment der Technischen Universität München
Department of General Surgery


Tempe, AZ
My Blogs:
My Twitter Hashtags:
[1]Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Cancer Epidemiology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Cancer Biology, Cancer Immunotherapy
Presented at Events Covering:
Areas of Interest:
General Comments:
BSN Rank: 6207 / 3065 (What's this?)
Accomplish Score: 30
Popularity Score: Unavailable
# in My Circle: 0
# in My Org(s): 39300
We'll Post Your CV for Free!
Speaking/Presenting-Abstract/Poster at Mtg: 0 (0 / 0)
Honors and Awards: 0 (0 / 0)
Clinical Trial Activity: 0 (0 / 0)
Grant Support: 0 (0 / 0)
Patents Pending: 0 (0 / 0)
Journal - Editor/Reviewer: 0 (0 / 0)
Peer Reviewed Papers, Books, Chapters: 5 (30 / 0)
  • Long-term uninterrupted therapy is essential for maximizing clinical benefits of antiangiogenic drugs (AADs) in cancer patients. ()
  • As treatment options for hepatocellular carcinoma (HCC) are currently limited, we evaluated the efficacy and safety of oral apatinib, a VEGFR-2 inhibitor, on patients with advanced HCC. ()
  • BACKGROUND: The thioredxin reductases 1 (TrxR1) is one of the major antioxidant and redox regulators in mammalian cells. ()
Pre/Non Reviewed Papers, Proceedings: 0 (0 / 0)
Membership in Professional Societies: 0 (0 / 0)
White Papers: 0 (0 / 0)
Registered on BiotechScienceNews: 0

3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.